Two vectors, pT7NScamAB and pRED, have been used for the functional expression of bacterial class I cytochrome P450 (P450) genes in Escherichia coli, which utilize putidaredoxin reductase (CamA) and putidaredoxin (CamB), and the reductase domain of a selfsufficient P450RhF respectively, for electron transfer from NAD(P)H to a P450 protein. We here compared the efficiency of bioconversion with the two vectors towards n-octane, cyclohexane, n-butylbenzene, and 2-n-butylbenzofuran using two well-characterized CYP153A genes, aciA and CYP153A13a (P450balk). As for n-octane bioconversion, aciA and pT7camAB was the best combination for the production of 1-octanol and 1,8-octanediol. As for the bioconversion of cyclohexane, n-butylbenzene and 2-n-butylbenzofuran, CYP153A13a with pRED achieved the most efficient bioconversion, as compared by conversion ratio per active CYP153A protein content. It was also found that 2-n-butylbenzofuran is biotransformed into 4-benzofuran-2-yl-butyric acid via 4-benzofuran-2-yl-butan-1-ol with E. coli cells expressing CYP153A.
The hydroxylation reactions of organic low-molecular-weight compounds such as alkanes, terpenes, and aromatic compounds are notable among a series of enzymatic reactions, since organic chemistry is substantially unable to mediate such reactions. Cytochromes P450 (P450) involve hydroxylation of vast ranges of organic molecules in regio-and sometimes stereo-specific manners. 1, 2) Several P450s can even hydroxylate alkanes that possess no active carbon atoms. 3, 4) P450s belonging to the CYP153 family have been characterized in bacteria utilizing alkanes as the sole carbon source, [4] [5] [6] [7] and have been found to mediate the terminal hydroxylation reactions of n-alkanes such as n-octane and n-hexane. 4, 7) Among microbial hosts, E. coli is the microorganism of choice for biotechnological applications, since extensive molecular genetic resources exist and it is fully amenable to genetic manipulation. Nodate et al. (2006) initially expressed functionally in E. coli a CYP153 gene encoding CYP153A13a (called P450balk) isolated from a marine bacterium Alcanivorax borkumensis SK2, using vector pRED. 4) The resulting recombinant E. coli cells converted n-octane into 1-octanol with an efficiency of 360-800 mg/l for 24 h. 4, 8) The E. coli cells expressing the P450balk gene were further shown to convert cyclohexane, n-butylbenzene, and 4-phenyl-1-butene into cyclohexanol, 4-phenyl-1-butanol, and 2-phenethyloxirane respectively. 8) Fujii et al. (2006) isolated a gene cluster including a CYP153A gene (named aciA) from a soil bacterium Acinetobacter sp. OC4, and showed that E. coli cells expressing this gene cluster, which contains the genes for a ferredoxin reductase and a ferredoxin in addition to aciA, produced a large amount of 1-octanol (2,550 mg/l) from n-octane after 24 h of incubation, and that part of 1-ocotanol was further converted into 1,8-octanediol (722 mg per liter at 24 h). 7) The two CYP153A proteins, AciA and P450balk (CYP153A13a), shared 62.1% amino acid identity. Their alignment is shown in Fig. 1 .
In order to act as terminal monooxygenases, usually P450s must be associated with one or two additional proteins to transfer two electrons from NAD(P)H to the heme domain of a P450 protein to perform the reductive cleavage of oxygen and subsequent substrate hydroxylation and H 2 O generation. 1, 9) The vast majority of bacterial P450s need a FAD-containing ferredoxin reductase to receive the electrons from NAD(P)H, and a ferredoxin, a small iron-sulfur protein, which in turn reduces P450 itself (the bacterial class I system). 9) P450cam (CYP101A1) is the well-characterized bacterial P450 that was isolated from Pseudomonas putida, which mediates the 5-exo hydroxylation reaction of camphor. 10) This P450 receives electrons from NADH by way of a ferredoxin reductase that was named putidaredoxin reductase (CamA; EC 1.18.1.3) and a ferredoxin (putidaredoxin; CamB), which belongs to the group of [2Fe-2S]. 1, 9) Mercian Corporation has developed a functional expression system of bacterial P450 genes by co-expressing the putidaredoxin reductase * Present address: KNC Bio Research Center, KNC Laboratories Co., Ltd., Murodani, Nishi-ku, Kobe 651-2241, Japan y To whom correspondence should be addressed. Present address: Central Laboratories for Frontier Technology, Kirin Holdings Co., Ltd., i-BIRD, Nonoichi-machi, Ishikawa 921-8836, Japan; Tel: +81-76-227-7525; Fax: +81-76-227-7557; E-mail: n-misawa@ishikawa-pu.ac.jp (camA) and putidaredoxin (camB) genes, whose vector was named pT7NS-camAB (see Fig. 2A ). Using this system, 213 bacterial P450s were tested for hydroxylation ability as to testosterone, and produced 24 stereoselective monohydroxylated products, 11) but this system does not always provide a suitable electron transfer chain to bacterial P450s. 12) Hence different optional systems have been desired for functional expression of bacterial P450 genes. P450RhF (CYP116B2), derived from Rhodobacter sp. NCIMB 9784, was found to be a novel self-sufficient P450 protein, in which the P450 domain is C-terminally fused to a reductase domain. 13) The C-terminal reductase domain contains a FMNbinding ferredoxin reductase part to receive electrons from NAD(P)H, and a [2Fe-2S] ferredoxin part. 14 Fig. 2B ). This vector made possible in E. coli functional expression of the P450cam gene (CYP101A1) and a P450bzo gene (CYP203A) that was derived from an environmental metagenome library to synthesize 5-exo hydroxycamphor and protocatechuate (3,4-dihydroxybenzoate) from camphor and 4-hydroxybenzoate respectively.
4) The pRED vector also enabled the functional expression in E. coli not only of the P450balk gene (CYP1531A13a) but also of eight CYP153A genes that originated from various environments, such as petroleum-contaminated soil and artificial sponges including hexane that were positioned in sea water. 8) We report here a comparison of two functional expression vectors for bacterial P450 genes in E. coli, pT7NS-camAB and pRED, using the two well-characterized CYP153A genes, aciA and CYP153A13a. Structures of plasmids pCYP-camAB (A) and pCYP-Red (B) containing a CYP gene inserted into vectors pT7NS-camAB and pRED respectively, and the P450 monooxygenase systems constituted with the expressed gene products. In pCYP-Red, an N-terminal P450 is designed to be fused to the reductase domain via the 16 amino acid linker region following the EcoRI site.
Materials and Methods
Bacterial strains and genetic manipulations. E. coli DH5 15) was used in DNA manipulations.
was used as the host in the functional expression of P450 genes. PCR amplifications were performed using KOD plus DNA polymerase version 2 (Toyobo, Osaka, Japan) and a thermal cycler (Applied Biosystems, Foster City, CA). Restriction enzymes and DNA-modifying enzymes were purchased from New England BioLabs (Beverly, CA) and Takara Bio (Ohtsu, Japan). Plasmid DNA was prepared with a QIAprep Miniprep Kit (Qiagen, Hilden, Germany). Nucleotide sequences were confirmed with Bigdye terminator cycle sequencing ready reaction kit version 3.1 (Applied Biosystems) and a model 3730 DNA analyzer (Applied Biosystems). All recombinant DNA techniques were conducted as described by Sambrook and Russell (2001) . 15) Construction of plasmids. Plasmid pBalk-Red, in which the P450balk gene is C-terminally fused to the P450RhF reductase domain via the 16 amino acid linker, was described elsewhere. 4) In order to construct pBalk-camAB, a 1.4-kb fragment of the P450balk gene was amplified from a template pBalk-Red using primers Balk-F-nde, 5
0 -GGGCATATGTCAACGAGTTCAAGTACAAGTAATG-3 0 and Balk-R-spe, 5
0 -CCCACTAGTTTATTTTTTAGCCGTCAACTTAACC-3 0 . The thermal conditions for PCR were 95 C/30 s, 20 cycles of (98 C/20 s, 55 C/30 s, 68 C/2 min), 72 C/5 min. The amplified DNA was digested with NdeI and SpeI and cloned into pT7NS-camAB. 16) To construct pAciA-Red, a 1.5-kb fragment of aciA was amplified from a template plasmid pAfrAciA carrying aciBAC genes from Acinetobacter sp. OC4 7) under the same thermal conditions, using primers Aci-F-nde, 5
0 -CCCCATATGAACTCAGTCGCAGAAA-TTTTTGAG-3 0 , and Aci-R-eco, 5 0 -CCGAATTCCGCTTTGGCAGT-CAGTTTGACCATC-3 0 . The amplified DNA was digested with NdeI and EcoRI and cloned into pRED. To construct pAciA-camAB, another aciA fragment was amplified under the same PCR conditions as for pAciA-Red, except for the use of a primer Aci-R-spe, 5
0 -CCC-ACTAGTCTACGCTTTGGCAGTCAGTTTGACCATC-3 0 , instead of Aci-R-eco. The amplified DNA fragment was digested with NdeI and SpeI, and inserted into pT7NS-camAB.
Growth conditions of recombinant E. coli expressing CYP153A genes. Individual plasmids, pAciA-camAB, pAciA-Red, pBalkcamAB, and pBalk-Red, were introduced into E. coli BL21 (DE3). Each recombinant E. coli was pre-cultured at 30 C with shaking in 3 ml of L-broth (1% tryptone, 0.5% yeast extract, 0.5% NaCl) containing 100 mg/ml of ampicillin (Ap). After 16 h of cultivation, 500 ml of the pre-culture was inoculated into 50 ml of L-broth containing 100 mg/ml of Ap, 100 mg/l of FeSO 4 -7H 2 O, 80 mg/ml of 5-aminolevulinic acid hydrochloride (ALA), and solutions of Overnight Express Autoinduction system 1 (1 ml of solution I, 2.5 ml of solution II and 50 ml of solution III; Novagen, Madison), and cultivation was continued with shaking for 24 h at 28 C. The cells were collected and suspended in 5 ml of 50 mM phosphate buffer (pH 7.2) containing 0.5% glycerol. This cell suspension solution was called Mixture for Bioconversion (MFB). The addition of glycerol is considered to stabilize recombinant E. coli cells for a P450 reaction besides the generation of NADH from NAD þ by oxidation from glycerol to glycerone.
CO difference spectral analysis. Two mM (final concentration) of dithiothreitol, 200 ml of BugBuster 10 Â ðNovagenÞ, and 1 ml of Benzonase Nuclease (Novagen) were added to 2 ml of each MFB. After 20 min of shaking at room temperature, cell debris and large parts of the membranes were removed by centrifugation at 8,000 rpm for 10 min. The soluble fraction was then used to measure CO-reduced CYP absorption with a spectrophotometer DU 640 (Beckman, Fullerton, CA). CO difference spectra were measured as described previously. 17) In order to calculate the amount of CYP functional form, an extinction coefficient of 91 mM À1 cM À1 was used [amount of CYP functional form ðnMÞ ¼ CO difference a peak at OD 450 nm (OD 450 nm-OD 490 nm)/91(mM À1 cM À1 ) Â 1,000,000].
Bioconversion of n-octane, cyclohexane, n-butylbenzene and 2-nbutylbenzofuran by individual recombinant E. coli cells. Each substrate for bioconversion (500 ml of n-octane, 500 ml of cyclohexane, and 10 mM of n-butylbenzene or 1 mM of 2-n-butylbenzofuran) was added to 1.5 ml of each MFB. After 24 h of incubation at 28 C with shaking, 100 ml of 6 N HCl and 1.5 ml of ethyl acetate were added and mixed. After centrifugation at 8,000 rpm for 10 min, the ethyl acetate phase was collected.
Analysis by gas chromatography of converted products. One ml of each ethyl acetate phase that contained products converted from n-octane, cyclohexane, or n-butylbenzene was applied to gas chromatography (GC-2010, Shimazu, Kyoto, Japan) in a DB-FFAP column (0:25 mm Â 0:25 mm ID Â 30 m, J & W Scientific, Folsum, CA), except for temperature program, which had an initial oven temperature of 40 C for 3 min, increased at rates of 20 C/min to 230 C, and 230 C for 2.5 min. GC-MS analysis of the converted products was also carried out, as described elsewhere.
8)
Analysis by high performance liquid chromatography (HPLC) of a converted product. Ten ml of the ethyl acetate phase containing a product converted from 2-n-butylbenzofuran was applied to HPLC (Waters 2695, Waters, Milford, Massachusetts) with an XTerra C 18 column (4:6 Â 100 mm length, 5 mm particle size, Waters) with a photodiode array detector (Waters 2996, Waters). Development was carried out at a flow rate of 1 ml/min with solvent A (5% acetonitrile, CH 3 CN, containing 20 mM phosphoric acid) for 3 min, and by a linear gradient from solvent A to solvent B (95% CH 3 CN containing 20 mM phosphoric acid) for 25 min, and then solvent B for 5 min, the maximum absorbance being monitored in a range of 200-500 nm.
Structural analysis of the product converted from 2-n-butylbenzofuran. The liquid phase (200 ml) converted from 1 mM of 2-nbutylbenzofuran was adjusted to pH 5 with 2 N HCl, and extracted with ethyl acetate (EtOAc; 100 ml Â 2). The organic layer was concentrated to dryness (153.2 mg), and purified by column chromatography on Silica Gel 60 (10 mm Â 300 mm, Merck, Darmstadt, Germany) using hexane-EtOAc (3:1) as the solvent. 
Results
Identification of the products converted from 2-nbutylbenzofuran through living cells of E. coli carrying pBalk-Red
As products converted from 2-n-butylbenzofuran with E. coli cells carrying plasmid pBalk-Red, pure 1 (6.6 mg) and 2 (1.2 mg) were obtained on the chromatography described in ''Materials and Methods.'' The molecular formula of 1 was determined to be C 12 H 14 O 2 by HREI-MS data. The 1 H and 13 C NMR spectra of 1
showed that the end methyl in 2-n-butylbenzofuran was oxidized to the corresponding primary alcohol. Thus 1 was identified as 4-benzofuran-2-yl-butan-1-ol (Fig. 3) . The molecular formula of 2 was determined to be C 12 H 12 O 3 by HRESI-MS data. The 1 H and 13 C NMR spectra of 2 showed that the end methyl in 2-nbutylbenzofuran was oxidized to the corresponding carboxylic acid. Thus 2 was identified as 4-benzofuran-2-yl-butyric acid (Fig. 3) . 4-Benzofuran-2-yl-butan-1-ol, which was synthesized from 2-n-butylbenzofuran with CYP153A13a (P450balk), appears to be further converted to 4-benzofuran-2-yl-butyric acid by endogenous alcohol and aldehyde dehydrogenases in E. coli, as such reactions are often observed.
18) It was the first report that CYP153 can catalyze the terminal hydroxylation of 2-n-butylbenzofuran.
Measurement of the functional forms of CYP153A proteins synthesized in individual recombinant E. coli cells
In order to measure the amounts of the active forms of CYP153 proteins synthesized in E. coli cells carrying the respective plasmids, pAciA-camAB, pAciA-Red, pBalk-camAB, and pBalk-Red, we performed CO difference spectral analysis using each MFB. The results are shown in Table 1 . The functional forms of the AciA and CYP153A13a proteins tended to be larger in the recombinant E. coli cells with pT7NS-camAB than in those with pRED.
Bioconversion of n-octane through living cells of E. coli expressing CYP153A genes
The results of bioconversion experiments on n-octane with recombinant E. coli cells carrying the various plasmids are shown in Figs. 4A and 5A. E. coli (pAciAcamAB) achieved the most efficient bioconversion from n-octane to form 646 mg of 1-octanol and 43 mg of 1,8-octanediol per liter of MFB in 24 h of culture, which corresponds to 0.225 mg of the products per 1 nmol of active protein (Fig. 5A) , while E. coli (pAciA-Red) biotransformed n-octane poorly (Fig. 4A) . On the other hand, E. coli (pBalk-camAB) and E. coli (pBalk-Red) bioconverted n-octane moderately to generate 204 mg and 365 mg of 1-octanol, and 27 mg and 26 mg of 1,8- octanediol per liter of MFB in 24 h of culture, respectively (Fig. 4A ). When these are compared by conversion ratio per active CYP153A13a protein content, obviously the former is inferior to the latter (Fig. 5A ). E. coli (pBalk-Red) synthesized 0.162 mg of the converted products per 1 nmol of active P450 protein after 24 h of cultivation (Fig. 5A) .
Bioconversion of cyclohexane through living cells of E. coli expressing CYP153A genes
The results of bioconversion experiments on cyclohexane with recombinant E. coli cells carrying the various plasmids are shown in Figs. 4B and 5B. Except for E. coli (pAciA-Red), the three E. coli transformants bioconverted cyclohexane into cyclohexanol (Fig. 4B) . As compared by conversion ratio per active CYP153A protein content, E. coli (pBalk-Red) achieved the highest level. It corresponded to 72.4 mg of cyclohexanol per 1 nmol of active P450 protein after 24 h of cultivation (Fig. 5B) .
Bioconversion of n-butylbenzene through living cells of E. coli expressing CYP153A genes
The results of bioconversion experiments on nbutylbenzene with recombinant E. coli cells carrying the various plasmids are shown in Figs. 4C and 5C. Except for E. coli (pAciA-Red), the three E. coli transformants converted n-butylbenzene into 4-phenyl-1-butanol (Fig. 4C) . As compared by conversion ratio per active CYP153A protein content, E. coli (pBalkRed) achieved the highest level. It corresponded to 0.102 mg of 4-phenyl-1-butanol per 1 nmol of active P450 protein after 24 h of cultivation (Fig. 5C ).
Bioconversion of 2-n-butylbenzofuran through living cells of E. coli expressing CYP153A genes
The results of bioconversion experiments on 2-nbutylbenzofuran with recombinant E. coli cells carrying the various plasmids are shown in Figs. 4D and 5D . Except for E. coli (pAciA-Red), the three E. coli transformants biotransformed 2-n-butylbenzofuran to form 4-benzofuran-2-yl-butan-1-ol or 4-benzofuran-2-yl-butyric acid (Fig. 4D) . As compared by conversion ratio per active CYP153A protein content, E. coli (pBalk-Red) achieved the highest level. It corresponded to 66.7 mg of the converted products per 1 nmol of active P450 protein after 24 h of cultivation (Fig. 5D) .
Discussion
In the present study, we compared two functional expression vectors for bacterial class I cytochrome P450 genes in E. coli, pT7NS-camAB, which has been frequently utilized, and pRED, which was constructed in 2005, using two well-characterized CYP153A genes, aciA and CYP153A13a (P450balk). The functional forms of the CYP153A proteins tended to be present in recombinant E. coli cells with pT7NS-camAB in larger amounts than with pRED. The aciA gene on pT7NS-camAB elicited the most efficient bioconversion of n-octane to synthesize 1-octanol and 1,8-octanediol after 24 h of cultivation. On the other hand, the CYP153A13a (P450balk) gene was fit for pRED rather than pT7NS-camAB. As compared by bioconversion ratio per active CYP153A protein content, the E. coli cells expressing CYP153A13a on pRED achieved the most efficient biotransformation of cyclohexane, nbutylbenzene, and 2-n-butylbenzofuran after 24 h of cultivation. It was an unexpected result that the aciA gene was hardly expressed on the pRED vector, since AciA and CYP153A13a are homologous over their entire regions (Fig. 1) . The 16 amino-acid linker of pRED might inhibit generation of an expected conformation of AciA and the pRED reductase domain complex. Judging from our unpublished results as well as this study, pT7NS-camAB appears to have broader adaptability for class I bacterial P450 genes, whereas pRED occasionally enables one to stabilize an active form of P450 protein, as observed in CYP153A13a. This should be reasonable, because the use of pRED generates a self-sufficient P450 protein as one single polypeptide chain to obtain electrons from NAD(P)H and catalyze a monooygenation reaction. This study revealed that the fusion protein composed of the CYP153A13a protein and the pRED reductase domain via the 16 amino acid linker sequence is a highly active monooxygenase for alkanes and alkyl aromatics. Structural analysis of this artificial enzyme is likely to contribute not only to the construction of a more stable and active CYP153A enzyme, but also to improvement of the pRED vector with broader adaptability for class I bacterial P450 genes. Such trials should enable one to achieve industrial applications, of CYP153A and other bacterial P450s for the construction of organic lowmolecular-weight compounds that are difficult to synthesize chemically. 
